BRPI0503488A - agente de tratamento para sìndrome de intestino irritável com diarréia predominante - Google Patents
agente de tratamento para sìndrome de intestino irritável com diarréia predominanteInfo
- Publication number
- BRPI0503488A BRPI0503488A BRPI0503488-4A BRPI0503488A BRPI0503488A BR PI0503488 A BRPI0503488 A BR PI0503488A BR PI0503488 A BRPI0503488 A BR PI0503488A BR PI0503488 A BRPI0503488 A BR PI0503488A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment agent
- bowel syndrome
- irritable bowel
- diarrhea
- predominant diarrhea
- Prior art date
Links
- 206010012735 Diarrhoea Diseases 0.000 title abstract 3
- 229940124415 agent for irritable bowel syndrome Drugs 0.000 title 1
- NTHPAPBPFQJABD-LLVKDONJSA-N ramosetron Chemical compound C12=CC=CC=C2N(C)C=C1C(=O)[C@H]1CC(NC=N2)=C2CC1 NTHPAPBPFQJABD-LLVKDONJSA-N 0.000 abstract 2
- 229950001588 ramosetron Drugs 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"AGENTE DE TRATAMENTO PARA SìNDROME DE INTESTINO IRRITáVEL COM DIARRéIA PREDOMINANTE". Composição farmacêutica para a terapia de síndrome de intestino irritável com diarréia em pacientes masculinos e femininos, contendo de 0,001 a 0,05 mg de cloridrato de ramosetron como uma dose diária ou uma quantidade molar equivalente de ramosetron ou seu outro sal farmaceuticamente aceitável como um ingrediente ativo.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2004/000896 WO2004066998A1 (ja) | 2003-01-31 | 2004-01-30 | 安定な経口用固形医薬組成物 |
| PCT/JP2004/006657 WO2005073220A1 (ja) | 2004-01-30 | 2004-05-12 | 下痢型過敏性腸症候群治療剤 |
| PCT/JP2005/001549 WO2005072730A1 (ja) | 2004-01-30 | 2005-01-27 | 下痢型過敏性腸症候群治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0503488A true BRPI0503488A (pt) | 2006-03-07 |
Family
ID=34829390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0503488-4A BRPI0503488A (pt) | 2004-01-30 | 2005-01-27 | agente de tratamento para sìndrome de intestino irritável com diarréia predominante |
Country Status (8)
| Country | Link |
|---|---|
| AU (1) | AU2005209112B2 (pt) |
| BR (1) | BRPI0503488A (pt) |
| CA (1) | CA2516433C (pt) |
| MX (1) | MXPA05009025A (pt) |
| NO (1) | NO20054002L (pt) |
| NZ (1) | NZ541656A (pt) |
| RU (1) | RU2314808C2 (pt) |
| WO (1) | WO2005072730A1 (pt) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0381422T3 (da) * | 1989-02-02 | 1997-03-10 | Yamanouchi Pharma Co Ltd | Tetrahydrobenzimidazolderivater |
| GB9721139D0 (en) * | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
| AR028970A1 (es) * | 2000-07-26 | 2003-05-28 | Solvay Pharm Gmbh | USO DE CILANSETRON O DE SUS SALES POR ADICIoN DE A CIDOS Y/O SOLVATOS FARMACOLoGICAMENTE COMPATIBLES PARA LA OBTENCIoN DE PREPARADOS FARMACEUTICOS PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL SíNDROME DEL INTESTINO IRRITABLE |
-
2005
- 2005-01-27 MX MXPA05009025A patent/MXPA05009025A/es active IP Right Grant
- 2005-01-27 WO PCT/JP2005/001549 patent/WO2005072730A1/ja active IP Right Grant
- 2005-01-27 RU RU2005127333/15A patent/RU2314808C2/ru not_active IP Right Cessation
- 2005-01-27 NZ NZ541656A patent/NZ541656A/en not_active IP Right Cessation
- 2005-01-27 CA CA002516433A patent/CA2516433C/en not_active Expired - Fee Related
- 2005-01-27 AU AU2005209112A patent/AU2005209112B2/en not_active Ceased
- 2005-01-27 BR BRPI0503488-4A patent/BRPI0503488A/pt not_active IP Right Cessation
- 2005-08-29 NO NO20054002A patent/NO20054002L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2005127333A (ru) | 2006-07-10 |
| CA2516433A1 (en) | 2005-08-11 |
| NZ541656A (en) | 2008-05-30 |
| AU2005209112B2 (en) | 2007-07-05 |
| NO20054002D0 (no) | 2005-08-29 |
| AU2005209112A1 (en) | 2005-08-11 |
| CA2516433C (en) | 2009-06-02 |
| WO2005072730A1 (ja) | 2005-08-11 |
| NO20054002L (no) | 2005-10-26 |
| RU2314808C2 (ru) | 2008-01-20 |
| MXPA05009025A (es) | 2006-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200107920B (en) | Apomorphine and sildenafil composition. | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| MX2009003372A (es) | Formas de dosificacion de pelicula no mucoadhesiva. | |
| MXPA05004778A (es) | Metodos de uso y composiciones que contienen compuestos inmunomoduladores para el tratamiento y manejo de enfermedades mieloproliferativas. | |
| CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
| PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
| NZ613291A (en) | Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| MX2012000275A (es) | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| MX344476B (es) | Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal. | |
| WO2007064448A3 (en) | Cancer treatment using fts and 2-deoxyglucose | |
| NZ595376A (en) | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | |
| AR040248A1 (es) | Farmaco para el tratamiento de la vejiga hiperactiva | |
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| EP4442321A3 (en) | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor | |
| TNSN07474A1 (en) | Dosage regimen for prasugrel | |
| SI1677806T1 (sl) | Postopki za zdravljenje akutnega in s preobremenitvijo povzročenega zvina in natega z uporabo hialuronske kisline | |
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| BRPI0510895A (pt) | formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t | |
| AR061233A1 (es) | Formulacion de liberacion prolongada de naltrexona | |
| MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. | |
| AR075866A1 (es) | Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica. | |
| NZ595798A (en) | Ectoparasiticidal methods and formulations | |
| TNSN06072A1 (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
| BRPI0410374A (pt) | composição farmacêutica que compreende valsartano |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014. |